Dry Powder and the Pressure to Move
When capital timelines press against system capacity
Bain’s 2026 Global Private Equity report puts the current state of the industry in three numbers worth holding side by side. Global dry powder sits at $1.3 trillion, the majority of it raised in 2022 and 2023 vintages that are now three to four years old and visibly aging. The unsold portfolio across the industry has grown to roughly 32,000 companies representing $3.8 trillion in unrealised value. And distributions to LPs as a share of NAV are stuck at 14% — a level not seen since 2008–09, and one Bain explicitly calls a new modern record after four straight years below historical averages.
Read together, those three numbers describe a system trying to recycle capital in two directions at once: pushing out new deployment from aging dry powder and pulling in liquidity from holdings that won’t move. None of the individual numbers is unusual in isolation. The combination is structural, and it lands on sequencing more directly than most fund-level commentary acknowledges.
The external clock
Every fund contains an implicit clock. Limited partners expect deployment within defined windows. Value creation has to be demonstrated within defined hold periods. Capital that sits idle erodes credibility; capital that sits unrealised constrains the next raise. The external cadence is rational — it disciplines capital allocation and prevents indefinite deferral of judgment.
Buy-and-build platforms run on more than LP timelines. They run on integration capacity, leadership bandwidth, and absorption limits that don’t automatically expand because dry powder did. The tension this piece is about is what happens when those clocks diverge — particularly now, when the LP-side clock is running faster than it has in fifteen years and the operator-side clock has not changed at all.
Sequencing under capital pressure
In a buy-and-build environment, sequencing is the system’s coordinating mechanism. It governs when complexity is introduced, how learning compounds, and whether integration effort declines over time. Sequencing converts strategy into trajectory, and capital pressure alters sequencing incentives in directions that aren’t obvious until afterward.
When dry powder ages, the cost of waiting rises. Deals that might have been deferred become urgent, platforms that are “nearly ready” get treated as ready, and targets that stretch distance slightly more than ideal become tolerable. Add-on selection criteria get applied more loosely than platform-selection criteria warrant — a conflation pattern the data picks up at the platform level only after the fact.
None of these shifts looks dramatic in isolation. But sequencing is sensitive to marginal changes, and introducing complexity earlier than capacity supports doesn’t fail immediately — it accumulates. Leadership attention fragments slightly, integration timelines extend slightly, exception handling rises slightly. From the outside, deal flow continues. From the inside, cadence shifts.
Guardrails and investor pressure
Every disciplined buy-and-build system needs guardrails. Guardrails aren’t rigid prohibitions; they’re boundaries that prevent capital availability from dictating pace. When investor pressure rises — and it has, with vintage 2022–23 dry powder now visibly aging into the back half of its deployment window — those guardrails get tested.
The question isn’t whether firms feel pressure to deploy. They do; Bain’s data is unambiguous on that. The question is whether the system can say no, or not yet. Saying no is costly: under-deployment risk, fundraising friction, reputational drag in competitive markets. Saying yes prematurely is also costly — it pulls forward complexity without expanding absorption capacity, and the cost surfaces months later in the next acquisition’s integration.
The interaction between guardrails and investor pressure is structural, not behavioural. It determines whether sequencing remains coordinated or becomes capital-driven. Most of the platforms I’ve watched make this choice quietly, without anyone naming it as a choice.
Capacity does not scale with dry powder
A common implicit assumption in strong fundraising cycles is that scale expands capability. Larger funds, larger platforms, larger teams. But leadership and operating capacity don’t scale linearly with capital under management. Hiring increases headcount; it doesn’t automatically increase shared judgment, integration fluency, or decision coherence. Integration discipline gets learned through repetition under manageable load — and when load increases too quickly, learning slows rather than compounds.
Capacity is built deliberately, and dry powder doesn’t build it. If anything, abundant capital can mask capacity constraints temporarily. Platforms keep acquiring, operating partners add initiatives, boards increase meeting cadence. The activity feels like momentum until absorption limits surface — usually one or two acquisitions later, and usually after the constraint has already become harder to undo.
The illusion of optionality
High-dry-powder environments are often described as offering optionality. More capital means more potential moves. Structurally, optionality only exists if the system retains flexibility — and when sequencing accelerates under pressure, optionality can narrow rather than expand.
Each acquisition introduces commitments that are hard to walk back: cultural, operational, financial. Integration choices harden architecture. Technology stacks consolidate. Leadership roles crystallise. Optionality increases when each move improves the next; it decreases when each move consumes more capacity than it builds. Capital availability doesn’t determine which path the system takes — sequencing discipline does.
Where this leaves operators in 2026
Two-thirds of LPs in the ILPA Sentiment Survey 2025–26 said they would accept extended holds for better MOIC, which gives some platforms permission to slow down. But that permission is conditional — it depends on the platform actually compounding MOIC during the extended hold. The platforms I’ve watched at the edge of their capacity usually arrive at the point of needing more time only after they’ve already used the time they had. For a platform already at the edge of its absorption capacity, extending the hold is the right call only if the additional time is being spent building capability, not buying more time to absorb the last acquisition.
Capital pressure isn’t uniformly distorting. External clocks can counteract inertia, prevent over-analysis, and force decision clarity. In platforms with under-utilised capacity, deployment pressure may align with readiness. In platforms that have already compounded learning and reduced integration load over time, increased pace may be sustainable. The question — and the place this piece comes from — is which kind of platform a given operator is actually running, and whether that read is honest.
Accumulation, not event
One quiet feature of capital-driven sequencing is that failure rarely shows up as a single event. There’s no obvious breaking point. Integration stretches slightly, leadership load stays elevated slightly longer, cadence between acquisitions shortens slightly, and operating routines revert to exceptions slightly more often. Each increment is manageable. The system appears intact. But trajectory shifts gradually from compounding to accumulation, and the distinction becomes visible only in hindsight — when optionality has narrowed and sequencing flexibility has diminished.
The question for buy-and-build in 2026
Dry powder will fluctuate. Investor timelines will exist. Capital will periodically outpace opportunity, and opportunity will periodically outpace capital. The question for buy-and-build platforms is whether the system’s coordinating logic remains intact under pressure — not how to eliminate the pressure.
Three operator-level questions map cleanly onto the Bain data:
Does sequencing still govern when complexity gets introduced, or has the deployment clock taken that role over?
Does integration discipline still reduce the load on the next acquisition, or are the last two integrations still bleeding capacity into the current one?
Does leadership capacity expand faster than commitments, or has the platform crossed the line where every additional yes consumes more capacity than the previous one built?
If those three mechanisms hold, the capital pressure becomes useful — it sharpens decisions that might have drifted otherwise. If they degrade, the same pressure becomes distortion. The external clock can’t be removed. Whether it dictates trajectory is something each platform decides for itself, usually one acquisition at a time.
Dry powder is a visible metric. Capacity is not. The tension between them is structural and recurring, and 2026 is the year that tension is sharpest in modern PE history. The platforms that come out of this period strongest will be the ones that took the question seriously while the data still left them room to.